Heeding the clarion call for sustainability
New and existing pharma facilities will have to meet higher benchmarks to ensure that they do not pollute the environment…
Author
Price caps are a band aid hiding larger issues
Pharma companies should not be the ones held responsible for the high prices of medicines
India’s AMR Policy – Get Updated!
Express Healthcare at Asia Society India's panel discussion on AMR in India: The Invisible Pandemic
CDSCO is blowin’ in the wind
The CBI has reportedly found cases with the same modus operandi: failing batches and then approving them for a price
By 2030, we want to treat one in five cancer patients in India: Lara Bezerra, MD Roche India
Lara Yumi Tsuji Bezerra, Managing Director, Roche India came to India with close to 24 years of pharma experience, across sales,…
Big Pharma to get bigger, but what about patients?
The second patent cliff is around the corner, as patents for branded molecules with cumulative global sales of over $ 251 billion…
Building super brands
Known as the 'Sinarest company', Mumbai-based Centaur Pharma has proved that super brands can be nurtured by mid-sized pharma…
Protect IP to grow GDP
The RCEP negotiation is one of the BJP-led NDA-2 government’s first challenges as it links directly to the stated goal to make…
Microsoft Sharepoint Online: A vaccine for US FDA’s 483s, Warning Letter plague?
Ram Balani, CEO, FDASmart, explains how a customised, list-based Sharepoint GxP search can enhance enterprise pharma SOPs with US…
Time for a policy push for pharma
Delayed implementation of the API policy has resulted in India’s dependence on China